Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that Philip Young, CEO and Director will be presenting virtually at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference taking place on Thursday, June 17, 2021.
- Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that Philip Young, CEO and Director will be presenting virtually at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference taking place on Thursday, June 17, 2021.
- H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference Details:
The Company's presentation will be available on-demand at the start of the conference. - Lobe is a life sciences company focused on psychedelic medicines.
- For further information please contact:
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.